Recent Price Movement and Market Context
On 9 December 2025, National Peroxide’s share price touched Rs.475, setting a fresh 52-week and all-time low. This price point comes after a sequence of five consecutive trading sessions with negative returns, cumulatively amounting to a decline of 8.56% over that period. The stock’s daily performance on this date showed a fall of 1.35%, underperforming the broader Sensex index, which declined by 0.73% on the same day.
The stock’s trading range has narrowed considerably, with fluctuations limited to just Rs.1, indicating subdued market activity and limited volatility. Furthermore, National Peroxide is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish trend.
Comparative Performance Against Benchmarks
Over various time horizons, National Peroxide’s stock performance has lagged behind major market indices and sector benchmarks. The one-month return stands at -18.36%, contrasting with the Sensex’s positive 1.52% over the same period. The three-month return is recorded at -21.51%, while the Sensex gained 4.17% during this timeframe.
Longer-term figures reveal a more pronounced disparity. The stock’s one-year return is -47.05%, whereas the Sensex posted a gain of 3.65%. Year-to-date performance shows a decline of 40.63% for National Peroxide, compared to an 8.12% rise in the Sensex. Over three and five years, the stock has shown no appreciable gains, remaining flat, while the Sensex has advanced by 35.86% and 83.25% respectively. The ten-year comparison further highlights the stock’s underperformance, with National Peroxide’s returns stagnant against the Sensex’s 237.44% growth.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Financial Metrics Reflecting Company Performance
National Peroxide’s financial indicators over recent years illustrate a challenging environment for profitability and growth. The company’s operating profits have shown a compound annual growth rate (CAGR) of -135.58% over the past five years, indicating a contraction in core earnings capacity.
Debt servicing ability appears constrained, with an average EBIT to interest ratio of 0.14, suggesting limited earnings before interest and taxes relative to interest obligations. This ratio points to a tight margin for covering debt costs.
Return on equity (ROE) averages at 1.90%, signalling modest profitability generated per unit of shareholders’ funds. This figure is relatively low compared to typical industry standards, reflecting subdued returns for equity investors.
Recent Earnings and Income Composition
In the latest six-month period, the company reported a profit after tax (PAT) of Rs.1.28 crore, which represents a contraction of 77.78% compared to the previous corresponding period. This decline underscores the pressures on the company’s bottom line.
Non-operating income has constituted a significant portion of profit before tax (PBT), accounting for 263.49%. This suggests that a substantial share of earnings is derived from sources outside the company’s primary business operations, which may affect the sustainability of profits.
Valuation and Risk Considerations
National Peroxide’s stock is currently trading at levels considered risky relative to its historical valuation averages. The past year has seen a return of -47.05%, accompanied by a 113% decline in profits, highlighting the challenges faced by the company in maintaining profitability.
Performance comparisons with the BSE500 index reveal underperformance over multiple periods, including the last three months, one year, and three years. This trend indicates that the stock has not kept pace with broader market movements and sector peers.
Considering National Peroxide ? Wait! SwitchER has found potentially better options in Commodity Chemicals and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Commodity Chemicals + beyond scope
- - Top-rated alternatives ready
Shareholding and Sector Placement
National Peroxide operates within the commodity chemicals industry and sector, a segment characterised by cyclical demand and sensitivity to raw material prices. The company’s majority shareholding rests with promoters, indicating concentrated ownership control.
The stock’s market capitalisation grade is relatively low, reflecting its micro-cap status within the broader market context.
Summary of Current Situation
National Peroxide’s stock has reached a critical juncture with its all-time low price of Rs.475, following a sustained period of negative returns and subdued trading activity. Financial metrics reveal contraction in operating profits, limited debt coverage capacity, and low returns on equity. Earnings have been impacted significantly, with recent profit figures showing marked declines and a heavy reliance on non-operating income components.
Comparisons with market indices and sector benchmarks highlight the stock’s underperformance over short and long-term periods. The trading below all major moving averages further emphasises the prevailing downward momentum.
These factors collectively illustrate the severity of the current situation for National Peroxide within the commodity chemicals sector.
Limited Time Only! Upgrade now and get 1 Year of Stock of the week worth Rs. 14,999 for FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
